Valued at a market cap of $44.3 billion, IDEXX Laboratories, Inc. (IDXX) is a leading provider of veterinary diagnostics and ...

IDEXX Laboratories (NasdaqGS:IDXX) has expanded its Fecal Dx antigen testing to detect taeniid tapeworm in companion animals.

Key Points Interested in IDEXX Laboratories, Inc.? Here are five stocks we like better. CEO Michael Erickson used a Stifel ...

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IDEXX Laboratories, Inc.’s IDXX consistent strong performance of the CAG (Companion Animal Group) segment is poised to help it grow in the upcoming quarters. Robust demand for its cloud-based ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal ...

One company that fits this best-of-both-worlds billing is Idexx Laboratories (IDXX 0.38%), offering leading pet healthcare diagnostics operations. Delivering annualized revenue and free-cash-flow ...

(Reuters) - IDEXX Laboratories raised its full-year profit and sales forecasts on Tuesday, betting on higher demand for its diagnostic tests and lab services as more pet owners visit veterinary ...

Idexx published its third-quarter figures well before market open that day. The company divulged that its revenue was almost $1.11 billion, up a sturdy 13% from the same period of 2024. Net income ...

IDEXX Laboratories, Inc.’s IDXX second-quarter growth was backed by the robust performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in international CAG ...